Literature DB >> 9780190

Peripheral blood-derived CD34+ progenitor cells: CXC chemokine receptor 4 and CC chemokine receptor 5 expression and infection by HIV.

M E Ruiz1, C Cicala, J Arthos, A Kinter, A T Catanzaro, J Adelsberger, K L Holmes, O J Cohen, A S Fauci.   

Abstract

The present study demonstrates cell surface expression of both CXC chemokine receptor 4 (CXCR4) and CC chemokine receptor 5 (CCR5), major coreceptors for T cell-tropic and macrophage-tropic strains of HIV, respectively, on CD34+ progenitor cells derived from the peripheral blood. CD34+ progenitor cells were susceptible to infection by diverse strains of HIV, and infection could be sustained for prolonged periods in vitro. HIV entry into CD34+ progenitor cells could be modulated by soluble CD4, HIV gp120 third variable loop neutralizing mAb and the cognate ligands for the CXCR4 and CCR5 HIV coreceptors. This study suggests that a significant proportion of the circulating progenitor cell pool may serve as a reservoir for HIV that is capable of trafficking the virus to diverse anatomic compartments. Furthermore, the infection and ultimate destruction of these progenitor cells may explain in part the defective lymphopoiesis in certain HIV-infected individuals despite effective control of virus replication during highly active antiretroviral therapy.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9780190

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  24 in total

1.  Bone marrow CD34(+) cells and megakaryoblasts secrete beta-chemokines that block infection of hematopoietic cells by M-tropic R5 HIV.

Authors:  M Majka; T Rozmyslowicz; B Lee; S L Murphy; Z Pietrzkowski; G N Gaulton; L Silberstein; M Z Ratajczak
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

2.  HIV-1 DNA is detected in bone marrow populations containing CD4+ T cells but is not found in purified CD34+ hematopoietic progenitor cells in most patients on antiretroviral therapy.

Authors:  Christine M Durand; Gabriel Ghiaur; Janet D Siliciano; S Alireza Rabi; Evelyn E Eisele; Maria Salgado; Liang Shan; Jun F Lai; Hao Zhang; Joseph Margolick; Richard J Jones; Joel E Gallant; Richard F Ambinder; Robert F Siliciano
Journal:  J Infect Dis       Date:  2012-01-24       Impact factor: 5.226

3.  Transcriptional regulation of the chemokine co-receptor CCR5 by the cAMP/PKA/CREB pathway.

Authors:  Anupam Banerjee; Vanessa Pirrone; Brian Wigdahl; Michael R Nonnemacher
Journal:  Biomed Pharmacother       Date:  2011-05-30       Impact factor: 6.529

Review 4.  New tools for quantifying HIV-1 reservoirs: plasma RNA single copy assays and beyond.

Authors:  Benedict B Hilldorfer; Anthony R Cillo; Guillaume J Besson; Margaret Anne Bedison; John W Mellors
Journal:  Curr HIV/AIDS Rep       Date:  2012-03       Impact factor: 5.071

5.  CCR5 and CXCR4 chemokine receptor expression and beta-chemokine production during early T cell repopulation induced by highly active anti-retroviral therapy.

Authors:  A Giovannetti; F Ensoli; F Mazzetta; M De Cristofaro; M Pierdominici; D S Muratori; V Fiorelli; F Aiuti
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

6.  Latent human cytomegalovirus enhances HIV-1 infection in CD34+ progenitor cells.

Authors:  Allen Ka Loon Cheung; Yiru Huang; Hau Yee Kwok; Min Chen; Zhiwei Chen
Journal:  Blood Adv       Date:  2017-01-16

7.  Compartmentalization of human immunodeficiency virus type 1 between blood monocytes and CD4+ T cells during infection.

Authors:  Jennifer A Fulcher; Yon Hwangbo; Rafael Zioni; David Nickle; Xudong Lin; Laura Heath; James I Mullins; Lawrence Corey; Tuofu Zhu
Journal:  J Virol       Date:  2004-08       Impact factor: 5.103

Review 8.  Cellular reservoirs of HIV-1 and their role in viral persistence.

Authors:  Aikaterini Alexaki; Yujie Liu; Brian Wigdahl
Journal:  Curr HIV Res       Date:  2008-09       Impact factor: 1.581

9.  Targeting c-Mpl for revival of human immunodeficiency virus type 1-induced hematopoietic inhibition when CD34+ progenitor cells are re-engrafted into a fresh stromal microenvironment in vivo.

Authors:  Prasad S Koka; Christina M R Kitchen; Srinivasa T Reddy
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

10.  Modeling Bone Marrow Progenitor Cell Differentiation and Susceptibility to HIV-1 Infection.

Authors:  Aikaterini Alexaki; Shane J Quiterio; Michael R Nonnemacher; Sonia Shah; Yujie Liu; Anupam Banerjee; Luna Li; Shendra Passic; Vanessa Pirrone; Evelyn Kilareski; Constantinos Petrovas; Brian Wigdahl
Journal:  MOJ Immunol       Date:  2014
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.